Doctor profile · Federal record
Dr. John Stone, M.D.
Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Boston, MA
- NPI 1053346924
- Accepts Medicare
- 36 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
Rheumatology Unit, 55 Fruit Street Bulfinch
Boston, MA 02114
(617) 726-2870
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- December 13, 2012
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Massachusetts #231034 · Maryland #D52121
- Medicaid
- MD #125061200
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053346924. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
219
Distinct HCPCS
3
Medicare allowed
$31,213
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 160 | 100 | $149 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 41 | 38 | $100 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 18 | 18 | $184 |
In context: peer comparison
Among 41 peers in Boston Rheumatology Physician, average services per provider: 68. This provider delivers 3.2× the peer median.Open Payments
Industry payments received
All-time total
$544,627
Transactions
40
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 21 | $524,910.46 | |
| Argenx US, INC. | 14 | $10,000.00 | |
| Alexion Pharmaceuticals, INC. | 1 | $4,725.00 | |
| Merck Sharp & Dohme LLC | 2 | $3,920.00 | |
| Sobi, INC | 1 | $962.00 | |
| Novartis Pharmaceuticals Corporation | 1 | $109.69 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
449
Patients
44
Total drug cost
$1,701,582
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 154 | 44 | $1,404 |
| Humira Pen (Adalimumab) | Brand | 37 | 0 | $336,234 |
| Actemra (Tocilizumab) | Brand | 35 | 0 | $219,221 |
| Humira(Cf) Pen (Adalimumab) | Brand | 33 | 0 | $394,351 |
| Xeljanz Xr (Tofacitinib Citrate) | Brand | 31 | 0 | $184,443 |
| Allopurinol | Generic | 22 | 0 | $217 |
| Actemra Actpen (Tocilizumab) | Brand | 21 | 0 | $149,443 |
| Enbrel (Etanercept) | Brand | 20 | 0 | $140,064 |
| Methotrexate (Methotrexate Sodium) | Brand | 18 | 0 | $875 |
| Creon (Lipase/Protease/Amylase) | Brand | 17 | 0 | $20,333 |
Hospital affiliations
Frequently asked questions
What is Dr. John Stone's medical specialty?
Dr. John Stone practices Rheumatology Physician in Boston, MA.
Where does Dr. John Stone practice?
Dr. John Stone practices at Rheumatology Unit, Boston, MA 02114. Office phone: 6177262870.
What is Dr. John Stone's NPI?
Dr. John Stone's National Provider Identifier (NPI) is 1053346924, issued by NPPES.
Does Dr. John Stone accept Medicare assignment?
Yes. Dr. John Stone accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Stone commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.